Skip to content
  • February 13, 2026
EuroAsia24 News EuroAsia24 News
×
EuroAsia24 News EuroAsia24 News
  • Home
  • Global
  • Political
  • Defense
  • Business
  • Health
  • Sports
  • Tech
  • Entertainment
  • Lifestyle
  • Home
  • Notches
Advertisment
Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease
Health

Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease

The Editorial Team April 20, 2025 Blockbuster, disease, drug, Dupixent, FDA, Inflammatory, nod, Notches, Regeneron, Sanofi, Skin

[ad_1] Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria,…

Read More
Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD
Health
The Editorial Team Approval, Biologic, COPD, drug, Dupixent, FDA, Notches, Regeneron, Sanofi 0 Comments

Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD

[ad_1] The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and…

Read More
September 29, 2024

CATEGORIES

  • Archive
  • Business
  • Defense
  • Entertainment
  • Global News
  • Health
  • Israel News
  • Lifestyle
  • Opinion
  • Political
  • Society
  • Sports
  • Technology
Advertisment
Eurasia24.com
  • About us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Euroasia24 is not responsible for the content of external sites. | Powered By SpiceThemes